MOZOBIL
MOZOBIL
Approved
DIN Number
02377225
Drug Class
Human
Market Date
Mar 26, 2012
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02377225
AIG Number0153050001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L03AX16 PLERIXAFOR
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PLERIXAFORActive
Strength: 20 MG / ML
Monograph: PLERIXAFOR